...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Intact charge variant analysis of ziv-aflibercept by cationic exchange liquid chromatography as a proof of concept: Comparison between volatile and non-volatile salts in the mobile phase
【24h】

Intact charge variant analysis of ziv-aflibercept by cationic exchange liquid chromatography as a proof of concept: Comparison between volatile and non-volatile salts in the mobile phase

机译:阳离子交换液相色谱完整ZiV-AfliBercept的完整电荷变异分析作为概念证据:流动阶段挥发性和非挥发性盐之间的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Ziv-aflibercept (ziv-AFL) is a complex fusion protein which is widely used in hospitals for the treatment of colorectal metastatic cancer. Charge variants are critical attributes for assessing post-transitional modifications (PMTs) that have to be controlled during the development and manufacture of these proteins and until their administration to patients. Cation exchange (CEX) chromatography is a charge-sensitive analytical method that is well suited for analysing charge variants in proteins. The aim of this paper is to analyse the charge variants of ziv-AFL in the medicine (Zaltrap (R)) when fresh and when degraded. Two CEX chromatographic methods were compared for this purpose. The former was an adaptation of the method used in the first published study in which charge variants were analysed via pH gradient elution using volatile, low ionic strength buffers with direct coupling to high-resolution Orbitrap mass spectrometry. The second method was developed and optimized during our research using the salt-mediated pH gradient mode and classical non-volatile, high ionic strength buffers which were incompatible with direct coupling with mass detection. Fresh and controlled degraded samples of ziv-AFL were used to evaluate the capacity of both CEX chromatographic strategies for detecting charge variants in ziv-AFL. In the controlled degradation study the samples of the medicine were subjected to three stress factors: temperature of 60 degrees C for three hours, freeze/thaw process -two cycles-, and exposure to light for twelve hours. The CEX chromatographic method with non-volatile salts in the mobile phase enabled better detection of charge variants degraded ziv-AFL samples than the method using volatile salts with lower ionic strength. In addition, the complexity of the mass spectra data generated made it impossible to identify the multicharge variant species of ziv-AFL. Although charge variants were not separated in ziv-AFL fresh sample, our results indicate that the method with non-volatile salts in the mobile phase could be used to characterize and track changes in the charge variant UV chromatographic profile of ziv-AFL in fresh and degraded samples, even though it cannot be coupled to a mass detector and there is therefore no information about mass. The increase of basic protein degraded compounds were the most important degradation pattern detected in ziv-AFL (Zaltrap (R) ). (C) 2020 Elsevier B.V. All rights reserved.
机译:Ziv-AfliBelcept(ZiV-AFL)是一种复杂的融合蛋白,广泛用于医院,用于治疗结直肠转移性癌症。电荷变体是评估在开发和制造这些蛋白质期间的过渡后改性(PMTS)的关键属性,直到他们向患者施用。阳离子交换(CEX)色谱是一种充满电敏感的分析方法,非常适合分析蛋白质中的电荷变体。本文的目的是分析新鲜,Zaltrap(R))中ZiV-AFL的电荷变体(Zaltrap(R))。为此目的进行比较了两种CEX色谱方法。前者是对第一公布研究中使用的方法的适应,其中通过使用挥发性的低离子强度缓冲液通过pH梯度洗脱来分析电荷变体,其具有直接耦合到高分辨率壁图质谱法。使用盐介导的pH梯度模式和经典的非挥发性,高离子强度缓冲剂在我们的研究期间开发和优化了第二种方法,该高离子强度缓冲剂与与质量检测的直接耦合不相容。用于评估CEX色谱策略的新鲜和受控的ZIV-AFL的可容量,用于检测ZIV-AFL中的电荷变体。在受控的降解研究中,将药物的样品进行三个应力因子:温度为60℃,冻结/解冻过程 - 循环 - ,暴露于12小时。在流动相中具有非挥发性盐的Cex色谱法使能更好地检测电荷变体,其比使用较低离子强度的挥发性盐的方法降解了ZiV-AFL样品。另外,产生的质谱数据的复杂性使得不可能识别ZIV-AFL的多种形变体。尽管在ZiV-AFL新鲜样品中,电荷变体未分离,但我们的结果表明,流动相中具有非挥发性盐的方法可用于表征和追踪新鲜的ZIV-AFL的电荷变体UV色谱分布的变化和跟踪变化。降解样品,即使它不能耦合到质量检测器,因此没有关于质量的信息。碱性蛋白质降解化合物的增加是ZIV-AFL中最重要的降解模式(Zaltrap(R))。 (c)2020 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号